Partnerships Drive Canada’s Booming Cannabis Industry


Ryan Allway

July 6th, 2017

News, Top News


Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, but analysts expect a dramatic shortfall in production. Licensed producers that have been around for a while often have high numbers of patients and limited supply capabilities, while newly licensed producers have a significant production capacity with few customers. This has created a unique opportunity for partnerships to bridge the gap and unlock value for everyone.

In this article, we will look at how partnerships are driving Canada’s cannabis industry towards greater efficiency as licensed producers work to meeting increasing demand.

Tremendous Growth Opportunity

Canada’s cannabis industry is projected to surpass C$22.6 billion in size over the coming years, according to Deloitte, driven by the legalization of recreational marijuana next year. The retail market is projected to be worth up to C$8.7 billion per year, while growing, testing, lighting, security, and ancillary products could increase that number to up to C$22.6 billion. Taxes, licensing fees, and tourism could further boost that figure as well.

Health Canada has approved 50 licensed producers to meet the growing demand for medical and recreational cannabis. The process for obtaining a license under the Access to Cannabis for Medical Purposes Regulations (ACMPR) is notoriously difficult and time-consuming with many companies undergoing a multi-year process with no guaranteed outcome, which has limited the number of applicants.

Despite the growing number of approvals, PI Financial analysts believe that the industry will face a shortfall over the coming years. The analyst believes that licensed producers will need to cultivate a total of 610,000 kilograms of cannabis to meet domestic and export demand by 2019, but existing capacity could result in a 200,000 kilogram shortfall. The rigorous process of becoming a licensed producer also continues to constrict supply.

Partnerships Maximize Efficiency

Many licensed producers have turned to partnerships to maximize efficiency by sharing excess inventory and cost-effectively expanding production capacity. Often times, these efforts are a win-win for both parties since they enable licensed producers to keep inventories low and efficiently meet patient demand as it rises. Patients also benefit with lower prices and increased availability regardless of the licensed producer they’re working with.

Aurora Partners with WeedMD

Aurora Cannabis Inc. (TSX-V: ACB) (OTCQB: ACBFF) recently announced a strategic partnership with WeedMD Inc. (TSX-V: WMD). Under the terms of the deal, WeedMD will provide wholesale dried medical cannabis to Aurora in exchange for best-in-class patient education services for its CanvasRx program. WeedMD has already made an initial sale to Aurora out of inventoried product as Aurora begins to share its educational expertise.

“This is a win-win relationship benefiting both companies,” said Aurora Cannabis Inc. CEO Terry Booth in a press release announcing the partnership. “We are always looking to expand our product offering, both in terms of quantity for sale and new strains, but we will only do so if we are highly confident that the new products meet the industry-leading Aurora standard … We look forward to building a deeper relationship as both companies continue to expand.”

WeedMD is focused on the long term care and senior living market. The combination of CEO Bruce Dawson-Scully’s deep experience in that industry with Aurora’s top notch patient counseling service should accelerate the company’s penetration of the potentially lucrative market.

Emerald Health Partners with Village Farms

Emerald Health Therapeutics Inc. (TSX-V: EMH) (OTC: TBQBF) recently announced a joint venture with Village Farms International Inc. (TSX: VFF) (OTC: VFFIF). Under the terms of the deal, Village Farms will contribute a 25-acre greenhouse facility located on a 50-acre property that Emerald will convert into an ACMPR-compliant facility. Both parties will have a 50% ownership stake in the joint venture that could become a large producer.

“Partnering with Village Farms, one of North America’s largest and most technologically-driven greenhouse growers, on this tremendous opportunity, is a very exciting development for Emerald,” said Emerald Health Executive Chairman Avtar Dhillon in the press release announcing the deal. “Village Farms is a global leader in greenhouse growing and, importantly, an expert in the complex matter of safety for agricultural consumables.”

Village Farms gains entry to the burgeoning cannabis industry, relying on Emerald Health’s experience with cannabis cultivation, genetics, and regulations. Emerald Health gains affordable access to greatly increased production space with a partner recognized as a leader in low cost and efficient greenhouse growing.

Cannabis Wheaton Connects the Industry

Cannabis Wheaton Income Corp. (TSX-V: CBW) recently announced a deal with ABcann Global Corp. (TSX-V: ABCN). Under the terms of the deal, Cannabis Wheaton will invest $30 million initially into ABcann as an equity investment. Following completion of that investment, Cannabis Wheaton will further finance a 50,000 square foot expansion in exchange for 50% of the net proceeds of future wholesale or retail sales from the new production area, along with an equity interest in the entire company.

ABcann is the sixth licensed producer in Cannabis Wheaton’s portfolio, but it’s their first publicly-traded producer with a sales license. This represents a key turning point for Cannabis Wheaton after just recently becoming a publicly-traded company itself. The deal is highly attractive and could provide internal rates of return in excess of 50% without any consideration for equity, as well as serve as a model for future agreements with public companies.

From ABcann’s side the deal enables corporate development under favorable financing terms, with the initial $15 million priced at C$2.25/share and the following $15 million priced at $2.25/share minimum, possibly higher. The stock has been trading in the $1/share range. More details can be found in the announcement. This financing adds $30 million to the $30 million cash the company already has on hand, putting ABcann on firm financial footing as it expands production and plans for further growth in preparation for the coming adult use legalization.

Looking Ahead

Canada’s cannabis industry is expected to be worth more than C$20 billion over the coming years, but analysts expect there to be a shortfall in supply. With a growing number of industry partnerships, the industry could help address these concerns in a way that’s a win-win-win for the investors, companies, and patients looking for access to high-quality medicine. Investors may want to take a look at these companies as the industry continues to evolve.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading